These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 7671255)
1. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Havre PA; Yuan J; Hedrick L; Cho KR; Glazer PM Cancer Res; 1995 Oct; 55(19):4420-4. PubMed ID: 7671255 [TBL] [Abstract][Full Text] [Related]
2. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro. Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691 [TBL] [Abstract][Full Text] [Related]
3. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059 [TBL] [Abstract][Full Text] [Related]
4. HPV-16 E6 oncoprotein induces mutations via p53-dependent and -independent pathways. Kim HJ; Guo W; Park NH Oncol Rep; 2000; 7(4):707-12. PubMed ID: 10854530 [TBL] [Abstract][Full Text] [Related]
5. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. Rampias T; Sasaki C; Weinberger P; Psyrri A J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448 [TBL] [Abstract][Full Text] [Related]
6. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692 [TBL] [Abstract][Full Text] [Related]
7. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855 [TBL] [Abstract][Full Text] [Related]
8. The early HPV16 proteins can regulate mRNA levels of cell cycle genes in human cervical carcinoma cells by p53-independent mechanisms. Fogel S; Riou G Virology; 1998 Apr; 244(1):97-107. PubMed ID: 9581783 [TBL] [Abstract][Full Text] [Related]
10. p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts. Cistulli CA; Kaufmann WK Cancer Res; 1998 May; 58(9):1993-2002. PubMed ID: 9581844 [TBL] [Abstract][Full Text] [Related]
11. Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Yu Y; Li CY; Little JB Oncogene; 1997 Apr; 14(14):1661-7. PubMed ID: 9135067 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860 [TBL] [Abstract][Full Text] [Related]
14. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
15. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells. Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856 [TBL] [Abstract][Full Text] [Related]
16. Abrogation of p53-induced G1 arrest by the HPV 16 E7 protein does not inhibit p53-induced apoptosis. Wang Y; Okan I; Pokrovskaja K; Wiman KG Oncogene; 1996 Jun; 12(12):2731-5. PubMed ID: 8700534 [TBL] [Abstract][Full Text] [Related]
17. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297 [TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression. Seewaldt VL; Dietze EC; Johnson BS; Collins SJ; Parker MB Cell Growth Differ; 1999 Jan; 10(1):49-59. PubMed ID: 9950218 [TBL] [Abstract][Full Text] [Related]
19. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Sdek P; Zhang ZY; Cao J; Pan HY; Chen WT; Zheng JW Int J Oral Maxillofac Surg; 2006 Jul; 35(7):653-7. PubMed ID: 16513324 [TBL] [Abstract][Full Text] [Related]
20. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma]. Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]